Robert Fox

A Cognitive Risk Calculator and Screening Tool for Primary Care Settings

National Institute on Aging · R33

PI · $3.2M · Cleveland Clinic Lerner Com-Cwru

Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - Resubmission

National Institute of General Medical Sciences · P20

Contact PI · $2M · Cleveland Clinic Foundation

Nevada Exploratory Alzheimer's Disease Research Center (NVEADRC)

National Institute on Aging · P20

Contact PI · $1.1M · Cleveland Clinic Foundation

Characterization and Quantification of Myelin in the Central Nervous System

National Institute of Biomedical Imaging and Bioengineering · R01

PI · $1.1M · Case Western Reserve University

Study Evaluating the Safety of Myeliviz Myelin-Targeting PET Agent

Principal investigator · Withdrawn · Early phase 1

Robert Fox

Safety of Bryostatin in Patients With MS

Principal investigator · Terminated · Phase 1

Robert Fox

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

Principal investigator · Completed · Phase 2

MediciNova